The Kelch-like ECH-associated protein 1 (KEAP1) and the nuclear factor erythroid-2-related factor 2 (NFE2L2) mutations were found in more than 20% patients with non-small cell lung cancer, which represented one of the most important genomic subtypes 11,12. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.